Offer - Urjas Oil for just ₹ 1 X
Gemizan Injection is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer. Gemizan Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Gemizan Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Gemizan Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Gemizan Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Gemizan Injection's effect during pregnancy is Unknown and Severe while nursing. It is important to know if Gemizan Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gemizan Injection related warnings section.
Gemizan Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Infections are examples of such conditions. Other contraindications of Gemizan Injection have been discussed in the sections ahead.
Drug interactions for Gemizan Injection have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Gemizan Injection, it is important to know that it is safe while driving, and is habit-forming.
Gemizan Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Gemizan Injection safe for pregnant women?
The effects of Gemizan on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Gemizan Injection safe during breastfeeding?
Taking Gemizan may lead to serious side effects if you are breastfeeding. Gemizan should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Gemizan Injection on the Kidneys?
Gemizan rarely affects the kidneys.
What is the effect of Gemizan Injection on the Liver?
The liver can be affected by Gemizan. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Gemizan only after medical advice.
What is the effect of Gemizan Injection on the Heart?
Gemizan is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Gemizan Injection unless your doctor advises you to do so -
Is this Gemizan Injection habit forming or addictive?
Gemizan Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Gemizan Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Gemizan Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Gemizan Injection cannot treat any kind of mental disorder.
Interaction between Food and Gemizan Injection
Due to a lack of research, nothing can be said about the consequences of taking Gemizan Injection together with food.
Interaction between Alcohol and Gemizan Injection
Due to lack of research, there is no information about the side effects of taking Gemizan Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614